A Northwest Indiana biomedical company and 2011 recipient of the Chanute Prize for Team Innovation has been selected as the “best provider of Oncology and Pathology Diagnostic tools” in the USA, according to AI Global Media, an UK online publication that has over 260,000 page views globally. That in itself merits attention, but there’s more, said co-founder Frank Szczepanski, President/CEO of IVDiagnostics, who with his brother Tom, helped launch the company in 2008. In their continuing pursuit to develop an academic model involving students and faculty to pursue collaboration for better innovation, IVDiagnostics Inc. is adding a new chapter as it develops better tools for measuring and monitoring circulating tumor cells (CTCs) starting with cancer. Since early September, this upstart company with a big vision is now likely making history as one of the first bio-commercial companies based at an Ivy Tech facility. “This gives students and faculty a front row seat in project-based learning experiences,” Frank said, who is now located in a lab in the north building of the Ivy Tech Gary-35th avenue facility. Add that as part of his mission, Frank is presenting weekly cancer talks to Applied Science and Nursing students at the new IUN Arts and Sciences Building. “We’re widening their horizons about cutting edge science and preparing them to be better practitioners as nurses and professionals in health care,” he said.